Moreover, Lee et al. has observed that treatment with ionizing radiation and the chemotherapeutic agent gemcitabine results in enrichment of the CD44+CD24+ESA+ population in human primary pancreatic cancer xenografts [31]. This evidence concerns the gene CD44 and familial pancreatic carcinoma.